Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
Titel:
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
Auteur:
Santoro, Armando Rimassa, Lorenza Borbath, Ivan Daniele, Bruno Salvagni, Stefania Van Laethem, Jean Luc Van Vlierberghe, Hans Trojan, Jörg Kolligs, Frank T Weiss, Alan Miles, Steven Gasbarrini, Antonio Lencioni, Monica Cicalese, Luca Sherman, Morris Gridelli, Cesare Buggisch, Peter Gerken, Guido Schmid, Roland M Boni, Corrado Personeni, Nicola Hassoun, Ziad Abbadessa, Giovanni Schwartz, Brian Von Roemeling, Reinhard Lamar, Maria E Chen, Yinpu Porta, Camillo